Eden Research (LON:EDEN) Shares Down 3.3% – Here’s What Happened

Shares of Eden Research plc (LON:EDEN) dropped 3.3% during mid-day trading on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The business has a 50-day moving average price of GBX 3.87 and a 200-day moving average price of GBX 3.95. The firm has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92.

Insider Activity

In other Eden Research news, insider Alexander John Abrey acquired 540,540 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,362.19). Also, insider Lykele van der Broek acquired 256,000 shares of the stock in a transaction that occurred on Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,958.74). Company insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.